|
SSRP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50418000000041E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02129999999912E-05 |
| Normal-vs-Stage2 |
8.566000E-02 |
| Normal-vs-Stage3 |
1.00410000003492E-06 |
| Normal-vs-Stage4 |
7.91290000000666E-05 |
| Stage1-vs-Stage2 |
6.658300E-02 |
| Stage1-vs-Stage3 |
2.263400E-01 |
| Stage1-vs-Stage4 |
7.208000E-01 |
| Stage2-vs-Stage3 |
1.590360E-02 |
| Stage2-vs-Stage4 |
8.527800E-02 |
| Stage3-vs-Stage4 |
5.977800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.71152999999258E-05 |
| Normal-vs-AfricanAmerican |
8.107700E-02 |
| Normal-vs-Asian |
5.773500E-04 |
| Caucasian-vs-AfricanAmerican |
2.063800E-01 |
| Caucasian-vs-Asian |
7.342400E-01 |
| AfricanAmerican-vs-Asian |
3.378600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4831000000326E-06 |
| Normal-vs-Female |
2.25769999999681E-05 |
| Male-vs-Female |
3.116000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.11079999999919E-05 |
| Normal-vs-Age(41-60Yrs) |
8.28760000000095E-05 |
| Normal-vs-Age(61-80Yrs) |
1.392650E-04 |
| Normal-vs-Age(81-100Yrs) |
2.938400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.138200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.821400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.363800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.717000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.843600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.180200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.795700E-02 |
| Classical-VS-Follicular |
2.046600E-01 |
| Classical-VS-Other |
5.881200E-01 |
| Classical-VS-Normal |
9.84149999999628E-05 |
| Tall-VS-Follicular |
4.077600E-01 |
| Tall-VS-Other |
9.260400E-01 |
| Tall-VS-Normal |
1.79124999999392E-05 |
| Follicular-VS-Other |
8.013400E-01 |
| Follicular-VS-Normal |
6.21179999999999E-05 |
| Other-VS-Normal |
1.519150E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1056999999991E-05 |
| Normal-vs-N1 |
4.54769999436166E-09 |
| N0-vs-N1 |
2.082100E-03 |
|
|
